ADVANCED FIBROSIS AND THE RISK OF LIVER DECOMPENSATION AMONG HIV/HCV-COINFECTED INDIVIDUALS: CONSEQUENCES FOR THE TIMING OF THERAPY AGAINST HCV

被引：0
|
作者：
Macias, J. [1 ]
Camacho, A. [2 ]
von Wichmann, M. A. [3 ]
Lopez-Cortes, L. F. [4 ]
Ortega, E. [5 ]
Tural, C. [6 ]
Rios, M. J. [7 ]
Merino, D. [8 ]
Tellez, F. [9 ]
Marquez, M. [10 ]
Pineda, J. A. [1 ]
机构：
[1] Hosp Univ Valme, Seville, Spain
[2] Hosp Univ Reina Sofia, Cordoba, Spain
[3] Hosp Donostia, San Sebastian, Spain
[4] Hosp Univ Virgen del Rocio, Seville, Spain
[5] Hosp Gen Valencia, Valencia, Spain
[6] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[7] Hosp Univ Virgen Macarena, Seville, Spain
[8] Complejo Hosp Huelva, Huelva, Spain
[9] Hosp Linea Concepc, Cadiz, Spain
[10] Hosp Univ Virgen de la Victoria, Malaga, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60476-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
474
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [1] Prevalence and risk factors for advanced liver fibrosis in HIV/HCV-coinfected individuals
    Vecchi, V. Li
    Mazzola, G.
    Soresi, M.
    Colletti, P.
    Mineo, M.
    Colomba, C.
    Di Carlo, P.
    La Licata, F.
    La Spada, E.
    Vizzini, G.
    Montalto, G.
    INFECTION, 2010, 38 : 83 - 84
  • [2] Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy
    Fuster, D
    Planas, R
    Muga, R
    Ballesteros, AL
    Santos, J
    Tor, J
    Sirera, G
    Guardiola, H
    Salas, A
    Cabré, E
    Ojanguren, I
    Barluenga, E
    Rey-Joly, C
    Clotet, B
    Tural, C
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (12) : 1293 - 1297
  • [3] HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe
    Amele, Sarah
    Sandri, Anastasia Karachalia
    Rodger, Alison
    Vandekerckhove, Linos
    Benfield, Thomas
    Milinkovic, Ana
    Duvivier, Claudine
    Stellbrink, Hans-Jurgen
    Sambatakou, Helen
    Chkhartishvili, Nikoloz
    Caldeira, Luis
    Laguno, Monserrat
    Domingo, Pere
    Wandeler, Gilles
    Gisinger, Martin
    Kuzovatova, Elena
    Dragovic, Gordana
    Knysz, Brygida
    Matulionyte, Raimonda
    Rockstroh, Jurgen Kurt
    Lundgren, Jens Dilling
    Mocroft, Amanda
    Peters, Lars
    HIV MEDICINE, 2022, 23 (06) : 684 - 692
  • [4] Risk of liver decompensation assessed in HIV/HCV coinfected individuals with advanced liver fibrosis: a faster countdown experience
    Alves, Joao Pedro
    Peres, Susana
    Borges, Fernando
    Miranda, Ana Claudia
    Baptista, Teresa
    Ventura, Fernando
    Antunes, Isabel
    Nina, Jaime
    Campos, Maria Jose
    Aldir, Isabel
    Mansinho, Kamal
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 99 - 99
  • [5] Risk of Liver Decompensation Among HIV/Hepatitis C Virus-Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy
    Macias, Juan
    Marquez, Manuel
    Tellez, Francisco
    Merino, Dolores
    Jimenez-Aguilar, Patricia
    Lopez-Cortes, Luis F.
    Ortega, Enrique
    von Wichmann, Miguel A.
    Rivero, Antonio
    Mancebo, Maria
    Santos, Jesus
    Perez-Perez, Montserrat
    Suarez-Lozano, Ignacio
    Romero-Palacios, Alberto
    Torres-Cornejo, Almudena
    Pineda, Juan A.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (10) : 1401 - 1408
  • [6] Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction
    Barokar, Jyoti
    McCutchan, Allen
    Deutsch, Reena
    Tang, Bin
    Cherner, Mariana
    Bharti, Ajay R.
    JOURNAL OF NEUROVIROLOGY, 2019, 25 (06) : 792 - 799
  • [7] Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction
    Jyoti Barokar
    Allen McCutchan
    Reena Deutsch
    Bin Tang
    Mariana Cherner
    Ajay R. Bharti
    Journal of NeuroVirology, 2019, 25 : 792 - 799
  • [8] Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients
    Loko, M. -A.
    Bani-Sadr, F.
    Winnock, M.
    Lacombe, K.
    Carrieri, P.
    Neau, D.
    Morlat, P.
    Serfaty, L.
    Dabis, F.
    Salmon, D.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (07) : E307 - E314
  • [9] Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals
    Hopkins, S
    Lambourne, J
    Farrell, G
    McCullagh, L
    Hennessy, M
    Clarke, S
    Mulcahy, F
    Bergin, C
    HIV MEDICINE, 2006, 7 (04) : 248 - 254
  • [10] PD-1 expression is linked to NK cell dysfunction and advanced liver fibrosis in HIV/HCV-coinfected individuals
    Polo, M. L.
    Urioste, A.
    Gonzalez Polo, V.
    Poblete, G.
    Martinez, A.
    Sisto, A.
    Rolon, M. J.
    Turk, G.
    Laufer, N.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 104 - 104
12345